COMMUNIQUÉS West-GlobeNewswire

Zelluna ASA [ZLNA]: Key information regarding reverse share split and change of ISIN
27/03/2025
Oslo, Norway, 27 March, 2025 Reference is made to the stock exchange notice published on 9 January 2025 regarding an extraordinary general meeting held in Zelluna ASA (the " Company "), where it was resolved to carry [...]
Nutrify Today C-Suite Sumflex to Unite Global Nutraceutical Leaders in Mumbai
27/03/2025
MUMBAI, India, March 27, 2025 (GLOBE NEWSWIRE) -- Nutrify Today C-Suite Sumflex 2025 will convene top executives, policymakers, investors, and medical leaders on May 8-9, at the Trident and Oberoi Hotels in Mumbai. [...]
Updated ASGE Clinical Practice Guideline Includes TIF 2.0 and cTIF for Management of GERD
27/03/2025
Endoscopic anti-reflux therapy recognized as evidence-based approach to providing relief of GERD symptoms. SOUTH JORDAN, Utah, March 27, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global [...]
Peer-Reviewed Studies on Intuitive’s Force Feedback Technology Demonstrate its Potential to Reduce Force on Tissue and Enhance Surgeon Performance
27/03/2025
SUNNYVALE, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced the publication of two peer-reviewed [...]
ZyVersa Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
27/03/2025
KEY HIGHLIGHTS: Phase 2a proof-of concept clinical trial for Cholesterol Efflux Mediator™ VAR 200 in patients with diabetic kidney disease (DKD) expected to begin H1-2025. Regulatory path for VAR 200’s lead indication, [...]
Jim Gibson to join PacBio as Chief Financial Officer
27/03/2025
MENLO PARK, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced Jim Gibson will join and be appointed as the [...]
Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study
27/03/2025
2,000+ Average-Risk Patient Study Seeks to Confirm Mainz Biomed’s Industry-Leading Results in the Detection of Advanced Precancerous Lesions (APL) in Independent Samples Study is on Track to Report Top-Line Results in [...]
Digital Utilities Ventures Secures $3.4M Contract to Deploy Easy FEN™ Sustainable Agriculture Units in Africa
27/03/2025
Pioneering Green Technology to Transform Food Security and Agricultural Productivity Key Highlights: Sustainable Agriculture Solution for Africa Digital Utilities Ventures (DUTV) has secured a $3.4 million contract to [...]
Femasys Announces Financial Results for Year Ended December 31, 2024, and Provides Corporate Update
27/03/2025
-- Company expands commercial product offering with FemBloc ® permanent birth control (delivery system) approval in Europe and signed partnerships for distribution in Spain -- ATLANTA, March 27, 2025 (GLOBE NEWSWIRE [...]
Alzheimer's Data Challenge Names Winners for Innovative Biomarker Research Competition
27/03/2025
Global Researchers Recognized for Trailblazing Projects in First-of-Its-Kind Data Competition WASHINGTON, March 27, 2025 (GLOBE NEWSWIRE) -- International non-profit organization The Global Alzheimer’s Platform [...]
Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra
27/03/2025
INBS set to capitalize on growing Spanish Drug Testing Market, anticipated to reach $448 million by 2030 Major Spanish accounts currently require 1,000 drug testing cartridges per month NEW YORK, March 27, 2025 (GLOBE [...]
Prime Biome: Best Probiotic Supplement? Prime Biome Redefines the Skin-Gut Cell Turnover Approach
27/03/2025
Prime Biome is a science-backed probiotic that rejuvenates skin and supports digestion. Learn where to buy Prime Biome gummies. ST. PETERSBURG, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- Prime Biome emerges as a science- [...]
Premier Health Announces CEO Departure
27/03/2025
MONTRÉAL, March 27, 2025 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA ) (the “ Corporation ”), a leading Canadian Healthtech company, announces that Martin Legault has resigned from his role as [...]
Oragenics, Inc. Provides Q1 2025 Shareholder Update on Strategic and Financial Progress
27/03/2025
ONP-002 Advances Toward Phase IIa Concussion Trial with Strengthened Financial Foundation and Industry Momentum SARASOTA, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology [...]
FibroBiologics Announces 2025 Annual Meeting of Stockholders
27/03/2025
HOUSTON, March 27, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of [...]
SS Innovations International, Inc. Achieves Another Milestone by Successfully Performing Over 2,000 km North-to-South Robotic Cardiac Telesurgery with its SSi Mantra 3 Surgical Robotic System
27/03/2025
The SSI Mantra 3 Surgical Robotic System enabled a seamless connection from SS Innovations headquarters in Gurugram, India to Aster CMI Hospital in Bengaluru, India covering a distance over 2,000 km. The SSi Mantra, [...]
Chemomab Reports Positive Results in Nebokitug Phase 2 PSC Open Label Extension Trial Showing Continued Broad and Substantial Improvements in Key Liver Biomarkers
27/03/2025
Reinforces potential of nebokitug to become the first approved drug with disease-modifying activity for PSC--a deadly disorder that currently has no effective treatments Treatment in PSC patients with moderate/advanced [...]
LIXTE Biotechnology Provides Update On Progress with Proprietary Compound, LB-100, to Treat Ovarian and Colorectal Cancer
27/03/2025
-Started Two New Clinical Trials, Collaborating with MD Anderson and The Netherlands Cancer Institute for Treatment of Ovarian and Colorectal Cancer- -Received Exclusive Patent License Agreement with the NIH on LB-100's [...]
ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025
27/03/2025
GARDEN CITY, NY, March 27, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, today announced that they will be [...]

Pages